Kidney Cancer Association

We're excited to share that the American Brain Tumor Association's Metastatic Brain Tumor Collaborative has announced a $50,000 research grant opportunity! This funding is dedicated to supporting high-risk, high-impact research on central nervous system (CNS) metastases. This grant opportunity was made possible through a collaboration between the American Brain Tumor Association, the Metastatic Breast Cancer Alliance, LUNGevity Foundation, the Melanoma Research Foundation, and the Kidney Cancer Association. Letters of Intent (LOIs) are being accepted through December 17, 2024, via the American Brain Tumor Association’s grant portal on ProposalCentral. Visit https://lnkd.in/guQrYUvN to learn more! #CNSMetastasis #BrainCancerResearch #InnovationInMedicineIn

Tomorrow is #GivingTuesday, and we're ready to Sock It To #KidneyCancer! Giving $50 or more gets you a pair of awareness socks 🧦 to proudly show your support. Donate today at https://bit.ly/4hSLtSP

*LAST DAY TO APPLY* - The Cancer Research Institute (CRI) and the Kidney Cancer Association (KCA) have teamed up to drive groundbreaking kidney cancer immunotherapy research through the CRI-KCA CLIP Grant! With this grant you can: - 🔬 Focus on innovative immunotherapy for kidney cancer - 👥 Support preclinical and translational research - 🧬 Drive progress in early detection, side effect reduction, and improving patient quality of life - 💡 Collaboration across disciplines to fuel new discoveries Grant Details: - Up to $300,000 over two years - Open to faculty holding a tenure-track or higher position - Letters of Intent due by December 1, 2024 📝 Learn more and apply: https://lnkd.in/gjsUGuHB #CancerResearch #KidneyCancerResearch

Annamaria shares a powerful message about her #kidneycancer journey, reminding us that our emotions and experiences are valid. After losing a kidney at 37, she reflects on the challenge of fully honoring her own cancer journey. 🧡 Listen to her episode: https://lnkd.in/enMCymTC

We are so grateful for you, our #KidneyCancer community. Your generosity supports critical patient resources and fuels life-changing research. Thank you for the gift of hope that continues to drive us towards a cure - we know we're closer than ever. Warm wishes today and every day 🧡 Happy Thanksgiving from the KCA! #HappyThanksgiving

We know how important it is to celebrate the journeys of those we care about. That’s why we offer the Honor Wall. Create a special tribute for someone you love or share your own journey. Our stories connect us and remind us that we’re never alone. 🧡 https://lnkd.in/ewgeNUCW

📣 The KCA's Patient Perspectives support group meeting scheduled for November 27th has been RESCHEDULED to Wednesday, December 4th. This will be the final meeting of 2024! 📣 https://lnkd.in/eH73Q4eN We'll be back in January 2025 on the last Wednesday of each month to kick off a new year of support and discussion. 🧡

🎙️ In the season two finale of Kidney Cancer Unfiltered, host Annamaria Scaccia sits down with her family for an honest conversation about navigating her cancer journey. Joined by her partner, Sam, and son, Kelly, they reflect on facing kidney and thyroid cancer together as a team. 🧡 Tune in here: https://lnkd.in/enMCymTC

In her guest blog, Susan Hill, caregiver and KCA community member, shares how she found peace by exploring new places with her husband during his #kidneycancer journey. Their story shows us that even small adventures can bring joy and strength. Read more for Susan’s reflections and tips for caregivers during #NationalFamilyCaregiversMonth: https://lnkd.in/euYnJrBP

The Kidney Cancer Impact Alliance met during the American Urological Association's #HealthPolicy Weekend. Alongside fellow advocates from the Chris "CJ" Johnson Foundation, Inc, Judy Nicholson Kidney Cancer Foundation (JNF), and VHL Alliance, we discussed the federal #kidneycancer research funding, care access, testing, early detection, and other issues about which to speak with one voice to our representatives. 🤝🧡 The day also included a panel discussion about increasing diversity and engagement in #clinicaltrials and what to expect from potential agency appointees in the coming months. We're excited to continue working together and making a difference for patients and families impacted by kidney cancer!